Cargando…
Distortion-product otoacoustic emissions and auditory brainstem responses sensitivity assessment in cisplatin-induced ototoxicity in rats
Cisplatin (cis-diamminedicloroplatinum) is an antineoplastic drug used in the treatment of a variety of cancers, especially head-and-neck cancer. Its ototoxicity, however, has been noted as a common side-effect which limits its use and causes significant morbidity. AIM: to assess distortion-product...
Autores principales: | de Freitas, Marcos Rabelo, da Silva, Viviane Carvalho, de Castro Brito, Gerly Anne, de Carvalho, José Valdir, Gomes, Raimundo Martins, de Albuquerque Ribeiro, Ronaldo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446066/ https://www.ncbi.nlm.nih.gov/pubmed/19784413 http://dx.doi.org/10.1016/S1808-8694(15)30483-3 |
Ejemplares similares
-
The role of apoptosis in cisplatin-induced ototoxicity in rats
por: De Freitas, Marcos Rabelo, et al.
Publicado: (2015) -
Amifostine otoprotection to cisplatin ototoxicity: a guinea pig study using otoacoustic emission distortion products (DPOEA) and scanning electron microscopy
por: Hyppolito, Miguel Angelo, et al.
Publicado: (2015) -
Comparison of the Effectiveness of Monitoring Cisplatin-Induced Ototoxicity with Extended High-Frequency Pure-Tone Audiometry or Distortion-Product Otoacoustic Emission
por: Yu, Kwang Kyu, et al.
Publicado: (2014) -
Reliability of Contralateral Suppression in Evoked Distortion Product Otoacoustic Emissions
por: Santos, Ana Carolina dos, et al.
Publicado: (2021) -
Evaluation of the Protective Effect of Beta Glucan on Amikacin Ototoxicity Using Distortion Product Otoacoustic Emission Measurements in Rats
por: Bayindir, Tuba, et al.
Publicado: (2013)